Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. The firm develops, markets, and licenses its patented immunotherapy candidate for MAGE A. It encompasses vaccines, oncolytic viruses, adjuvants, and adoptive t-cell technologies. The company was founded by Anton Dormer and Mahesh Narayanan in 2012 and is headquartered in Bethesda, MD.